World's Best Scientists 2026 revealed!
Vittorio Pengo

Vittorio Pengo

D-Index & Metrics

Medicine

D-Index
84
Citations
33666
World Ranking
14908
National Ranking
579

Vittorio Pengo publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Vittorio Pengo sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 508 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Vittorio Pengo D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Vittorio Pengo sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Vittorio Pengo is affiliated with the University of Padua in Italy, contributing extensively to the field of medicine with a focus on cardiology, rheumatology, hematology, and internal medicine. Their research reflects particular expertise in the domains of systemic lupus erythematosus, platelet disorders, atrial fibrillation management, venous thromboembolism, and blood coagulation mechanisms.

The scientist has published 323 papers predominantly in the field of medicine, with subfields including cardiology and cardiovascular medicine (88 publications), rheumatology (65), hematology (53), internal medicine (28), and surgery (22). Their work addresses several main topics:

  • Systemic Lupus Erythematosus Research
  • Platelet Disorders and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Blood Coagulation and Thrombosis Mechanisms
  • Heparin-Induced Thrombocytopenia and Thrombosis

Pengo's research is frequently published in specialized venues including the Journal of Thrombosis and Haemostasis (13 publications), International Journal of Cardiology (7), European Heart Journal (7), Thrombosis Research (6), and Seminars in Thrombosis and Hemostasis (6).

Frequent collaborators in their research include Gentian Denas, Emilia Antonucci, Gualtiero Palareti, María Laura Bertolaccini, and Hannah Cohen, with collaboration counts ranging from 24 to 32 joint works.

Recent significant papers authored or coauthored by Vittorio Pengo include:

  • Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis, 2020, Journal of Thrombosis and Haemostasis
  • 2023 ACR/EULAR antiphospholipid syndrome classification criteria, 2023, Annals of the Rheumatic Diseases
  • The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, 2023, Arthritis & Rheumatology
  • Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, 2020, Journal of Thrombosis and Haemostasis
  • Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes, 2022, Journal of the American College of Cardiology

Best Publications

  • Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

    Vittorio Pengo;Anthonie W. A. Lensing;Martin H. Prins;Antonio Marchiori

  • Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT)

    Gualtiero Palareti;Nicoletta Leali;Sergio Coccheri;Mario Poggi

  • Update of the guidelines for lupus anticoagulant detection

    Vittorio Pengo;Armando Tripodi;G. Reber;Jacob H. Rand

  • EULAR recommendations for the management of antiphospholipid syndrome in adults

    Maria G Tektonidou;Laura Andreoli;Marteen Limper;Zahir Amoura

  • Chronic Thromboembolic Pulmonary Hypertension

    Nick H. Kim;Marion Delcroix;David P. Jenkins;Richard Channick

  • The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients

    Paolo Prandoni;Franco Noventa;Angelo Ghirarduzzi;Vittorio Pengo

  • d-Dimer Testing to Determine the Duration of Anticoagulation Therapy

    Gualtiero Palareti;Benilde Cosmi;Cristina Legnani;Alberto Tosetto

  • Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.

    Vittorio Pengo;Gentian Denas;Giacomo Zoppellaro;Seena Padayattil Jose

  • Clinical course of high-risk patients diagnosed with antiphospholipid syndrome

    Vittorio Pengo;Amelia Ruffatti;C Legnani;P Gresele

  • Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

    G. Ruiz-Irastorza;M. J. Cuadrado;I. Ruiz-Arruza;Robin L Brey

  • The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants.

    Perumal Thiagarajan;Vittorio Pengo;Sandor S. Shapiro

  • Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

    Harumi Takahashi;Grant R Wilkinson;Edith A Nutescu;Takashi Morita

  • PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2

    Sergio Dalla-Volta;Antonio Palla;Annamaria Santolicandro;Carlo Giuntini

  • Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.

    Vittorio Pengo;Amelia Ruffatti;Cristina Legnani;Sophie Testa

  • Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor: A Systematic Review

    Alfonso Iorio;Clive Kearon;Esmeralda Filippucci;Maura Marcucci

  • Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance

    Maria Gabriella Scordo;Maria Gabriella Scordo;Maria Gabriella Scordo;Vittorio Pengo;Vittorio Pengo;Vittorio Pengo;Edoardo Spina;Edoardo Spina;Edoardo Spina;Marja Liisa Dahl;Marja Liisa Dahl;Marja Liisa Dahl

  • Antibody profiles for the diagnosis of antiphospholipid syndrome.

    Vittorio Pengo;Alessandra Biasiolo;Cinzia Pegoraro;Umberto Cucchini

  • Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation : a randomised, open-label, non-inferiority trial

    M.G. Bousser;J. Bouthier;H.R. Buller;A.T. Cohen

  • The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study.

    B. De Laat;V. Pengo;I. Pabinger;J. Musial

  • Chronic thromboembolic pulmonary hypertension

    Michael Aschermann;Pavel Jansa;David Ambrož;Pavel Poláček

Frequent Co-Authors

Amelia Ruffatti
Amelia Ruffatti University of Padua
Paolo Prandoni
Paolo Prandoni University of Padua
Armando Tripodi
Armando Tripodi University of Milan
Sabino Iliceto
Sabino Iliceto University of Padua
Paolo Gresele
Paolo Gresele University of Perugia
Angela Tincani
Angela Tincani University of Brescia
Munther A. Khamashta
Munther A. Khamashta King's College London
Ricard Cervera
Ricard Cervera University of Barcelona
Walter Ageno
Walter Ageno University of Insubria
Pier Luigi Meroni
Pier Luigi Meroni Istituto Auxologico Italiano

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn't always mean becoming a physician. There are a variety of online degrees and career pathways that can lead to rewarding roles in the healthcare industry. If you're looking for a hands-on patient care position, you might consider what is the easiest nursing school to get into for a more accessible entry route into nursing programs.

Not all students wish to take traditional entrance exams. If that's your case, you can explore nursing schools that don't require teas or hesi, which can help simplify your application process.

For those interested in the administrative or technical side of healthcare, fields like medical billing and coding are in demand and easy to access remotely. Check out the best online medical billing and coding schools to find accredited and flexible options.

Finally, a leadership path may appeal to you. Earn a fast-tracked management degree from one of the healthcare administration degrees available online to quickly advance your career. Each of these pathways provides unique opportunities to make a difference in healthcare.

Best Scientists Citing Vittorio Pengo

Trending Scientists

Recently Published Articles